Sex workers can be screened too often: A costeffectiveness analysis in Victoria, Australia

Sexually Transmitted Infections

Volumn 86, Issue 2, 2010, Pages 117-125

  Wilson, David P ^a   Heymer, Kelly Jean ^a   Anderson, Jonathan ^a   O'Connor, Jody ^a   Harcourt, Christine ^a,b   Donovan, Basil ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b SYDNEY EYE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUSTRALIA; CHLAMYDIASIS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC KIT; GONORRHEA; HEALTH CARE POLICY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MATHEMATICAL MODEL; PRIORITY JOURNAL; PROSTITUTION; QUALITY OF LIFE; SCREENING; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; VIRUS TRANSMISSION;

CONDOMS; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; MALE; MASS SCREENING; PRACTICE GUIDELINES AS TOPIC; PROSTITUTION; QUALITY-ADJUSTED LIFE YEARS; SEXUALLY TRANSMITTED DISEASES; TIME FACTORS; VICTORIA;

EID: 77950158256     PISSN: 13684973     EISSN: 14723263     Source Type: Journal    
DOI: 10.1136/sti.2009.036673     Document Type: Article

References (56)

1. Prostitution Control Act 1994 (Victoria) and prostitution control (amendment) act 1997. www.austlii.eduau/au/legis/vic/consol-act/pca1994295/.
2. Lee DM, Binger A, Hocking J, et al. The incidence of sexually transmitted infections among frequently screened sex workers in a decriminalised and regulated system in Melbourne. Sex Transm Infect 2005;81:434-6.
3. Gold MSJ, Russell L, Weinstein M. Cost effectiveness in health and medicine. New York: OUP, 1996.
4. de Vincenzi I. A longitudinal study of human immunodeficiency virus transmission by heterosexual partners. European Study Group on Heterosexual Transmission of HIV. N Engl J Med 1994;331:341-6.
5. Padian NS, Shiboski SC, Glass SO, et al. Heterosexual transmission of human immunodeficiency virus (HIV) in northern California: results from a ten-year study. Am J Epidemiol 1997;146:350-7.
6. Gray RH, Wawer MJ, Brookmeyer R, et al. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 2001;357:1149-53.
7. Wawer MJ, Gray RH, Sewankambo NK, et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis 2005;191:1403-9.
8. Mastro TD, Satten GA, Nopkesorn T, et al. Probability of female-to-male transmission of HIV-1 in Thailand. Lancet 1994;343:204-7.
9. Garnett GP, Aral SO, Hoyle DV, et al. The natural history of syphilis. Implications for the transmission dynamics and control of infection. Sex Transm Dis 1997;24:185-200.
10. Clark EG. Studies in the epidemiology of syphilis: epidemiological investigations in a series of 996 cases of acquired syphilis. J Vener Dis Inf 1940;21:349-369.
11. Klingbeil LJ, Clark EG. Studies in the epidemiology of syphilis: III. Conjugal syphilis: a statistical study of a series of 226 married patients whose spouses were examined. J Vener Dis Inf 1941;22:1-6.
12. Schober PC, Gabriel G, White P, et al. How infectious is syphilis? Br J Vener Dis 1983;59:217-9.
13. von Werssowetz AJ. The incidence of infection in contacts of early syphilis. J Vener Dis Inf 1948;29:132-7.
14. Smith DC, Brumfield WA. Tracing the transmission of syphilis. JAMA 1933;101:1955-7.
15. Schrijvers D, Josse R, Trebucq A, et al. Epidemiologic treatment of contacts to infectious syphilis. Public Health Rep 1963;78:966-70.
16. Moore MB, Price EV, Knox JM, et al. Epidemiologic treatment of contacts to infectious syphilis. Public Health Rep 1963;78:966-70.
17. Schroeter AL, Turner R, Lucas JB, et al. Therapy for incubation syphilis. JAMA 1971;218:711-3.
18. Alexander LJ, Schoch AG. Prevention of syphilis. Arch Derm Syphilol 1949;59:1-10.
19. Quinn TC, Gaydos C, Shepherd M, et al. Epidemiologic and microbiologic correlates of chlamydia trachomatis infection in sexual partnerships. JAMA 1996;276:1737-42.
20. Regan DG, Wilson DP, Hocking JS. Coverage is the key for effective screening of chlamydia trachomatis in Australia. J Infect Dis 2008;198:349-58.
21. Katz BP, Caine, Jones RB. Estimation of transmission probabilities for chlamydial infection. International symposium on human chlamydial infections. New York: Cambridge University Press, 1990:567-70.
22. Holmes KK, Johnson DW, Trostle HJ. An estimate of the risk of men acquiring gonorrhea by sexual contact with infected females. Am J Epidemiol 1970;91:170-4.
23. Hook EW, Handsfield HH. Gonococcal infections in the adult. In: Wasserheit JN, ed. Sexually transmitted diseases. 3rd edn. New York: McGraw Hill, 1999:451-66.
24. White PJ, Ward H, Cassell JA, et al. Vicious and virtuous circles in the dynamics of infectious disease and the provision of health care: gonorrhea in Britain as an example. J Infect Dis 2005;192:824-36.
25. Turner KM, Garnett GP, Ghani AC, et al. Investigating ethnic inequalities in the incidence of sexually transmitted infections: mathematical modelling study. Sex Transm Infect 2004;80:379-85.
26. Hooper RR, Reynolds GH, Jones OG, et al. Cohort study of venereal disease. I: the risk of gonorrhea transmission from infected women to men. Am J Epidemiol 1978;108:136-44.
27. Davis KR, Weller SC. The effectiveness of condoms in reducing heterosexual transmission of HIV. Fam Plann Perspect 1999;31:272- 9.
28. Weller SC, Davis KR. Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database Syst Rev 2002(1):CD003255.
29. Pinkerton SD, Abtramson PR. Effectiveness of condoms in preventing HIV transmission. Soc Sci Med 1997;44:1303-12.
30. Weller SC. A meta-analysis of condom effectiveness in reducing sexually transmitted HIV. Soc Sci Med 1993;36:1635-1644.
31. Fitch TJ, Stine C, Hagar DW, et al. Condom effectiveness: factors that influence risk reduction. Sex Transm Dis 2002;29:811-7.
32. Reece M, Herbenick D, Sanders SA, et al. Breakage, slippage and acceptability outcomes of a condom fitted to penile dimensions. Sex Transm Infect 2008;84:143-9.
33. Richters J, Donovan B, Gerofi J, et al. Low condom breakage rate in commercial sex. Lancet 1988;2(8626e8627):1487-8.
34. Rissel CE, Richters J, Grulich AE, et al. Sex in Australia: experiences of commercial sex in a representative sample of adults. Aust N Z J Public Health 2003;27:191-7.
35. Carael M, Slaymaker E, Lyerla R, et al. Clients of sex workers in different regions of the world: hard to count. Sex Transm Infect 2006;82(Suppl 3):iii26-33.
36. Read PJ, O'Connor J, Wilson D, et al. How many sex workers are there in Sydney, Australia? London: International Society for Sexually Transmitted Diseases Research, 2009.
37. Schackman BR, Gebo KA, Walensky RP, et al. The lifetime cost of current human immunodeficiency virus care in the United States. Med Care 2006;44:990-7.
38. Archived consumer price index detailed report information: bureau of labor statistics.
39. Purchasing Power Parities. http://www.oecd.org/dataoecd/61/54/18598754. pdf. (accessed 1st December 2008).
40. Hornberger J, Holodniy M, Robertus K, et al. A systematic review of cost-utility analyses in HIV/AIDS: implications for public policy. Med Decis Making 2007;27:789-821.
41. Siegel JE, Weinstein MC, Russell LB, et al. Recommendations for reporting costeffectiveness analyses. Panel on cost-effectiveness in health and medicine. JAMA 1996;276:1339-41.
42. Donovan B, O'Connor JL, Harcourt C, et al. Law and sexworker health (LASH) project. London: International Society for STD Research Conference, 2009.
43. Chesson HW, Collins D, Koski K. Formulas for estimating the costs averted by sexually transmitted infection (STI) prevention programs in the United States. Cost Eff Resour Alloc 2008;6:10.
44. Walleser S, Salkeld G, Donovan B. The cost effectiveness of screening for genital Chlamydia trachomatis infection in Australia. Sex Health 2006;3:225-34.
45. Chen MY, Donovan B. Genital Chlamydia trachomatis infection in Australia: epidemiology and clinical implications. Sex Health 2004;1:189-96.
46. HIV/AIDS, Viral Hepatitis and Sexually Transimissble Infections in Australia. Annual surveillance report. Sydney, Australia: National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, 2008.
47. World Health Organization. International classication of diseases-version 10, 2007. Geneva, Switzerland: WHO. http://www.who.int/ classifications/icd/en/
48. Department of Health and Ageing. National Admitted Patient Care Collection (NAPCC) 2004-05 clinical profiles 2004-05, 2005. Canberra, Australia: Australian Government, Department of Health and Ageing.
49. Department of Health and Ageing. Round 11 (2006-07) cost reportdpublic version 5.1. Canberra: Department of Health and Ageing, 2007.
50. Department of Health and Ageing. Pharmaceutical Benefits Schedule. Australian Government, Department of Health and Ageing, 2008.
51. Medicare Australia. MBS online. Australia: Medicare Australia, 2008.
52. Tengs TOWA. One thousand health-related quality of life estimates. Canberra, Australia: Med Care 2000;38:583-637
53. Ventegodt S. Sex and the quality of life in Denmark. Arch Sex Behav 1998;27:295-307.
54. Terris M. Urethritis. eMedicine, 2008:8. http://emedicine.medscape.com/
55. Sabanegh ES. Epididymitis. eMedicine, 2008. http://emedicine.medscape.com/
56. Behrman A. Gonorrhea. eMedicine, 2008. http://emedicine. medscape.com/